PDK3: The Research and Development of a Potential Drug Target

Target Name: PDK3

NCBI ID: G5165

PDK3

Other Name(s): pyruvate dehydrogenase kinase, isoenzyme 3 | hCG_18655 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (isoform 1) | GS1-358P8.4 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | CMTX6 | Pyruvate dehydrogenase kinase, isozyme 3, isoform CRA_a | Pyruvate dehydrogenase kinase 3, transcript variant 1 | cDNA FLJ60191, highly similar to Pyruvate dehydrogenase (lipoamide) kinase isozyme 3 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (isoform 2) | Pyruvate dehydrogenase kinase 3, transcript variant 2 | PDK3 variant 2 | Pyruvate dehydrogenase, lipoamide, kinase isozyme 3, mitochondrial | Pyruvate dehydrogenase kinase, isoenzyme 3 | PDK3 variant 1 | Pyruvate dehydrogenase kinase isoform 3 | pyruvate dehydrogenase, lipoamide, kinase isozyme 3, mitochondrial | PDK3_HUMAN | pyruvate dehydrogenase kinase 3

PDK3: The Research and Development of a Potential Drug Target

PDK3, or pyruvate dehydrogenase kinase, is an enzyme that plays a crucial role in the metabolism of pyruvate, a critical intermediate step in the citric acid cycle. The failure of PDK3 to function correctly can lead to a range of physiological and therapeutic issues, including cancer, neurodegenerative diseases, and metabolic disorders. As a result, PDK3 has emerged as a promising drug target for a variety of therapeutic applications.

In recent years, the study of PDK3 has led to a greater understanding of its role in various biological processes. PDK3 has been shown to play a key role in the regulation of cellular metabolism, and is involved in the production of ATP, the energy currency of the cell. It has also been shown to be involved in the development and maintenance of muscle mass, and has been linked to the progression of certain diseases, such as cancer.

PDK3 has also been shown to be a potential drug target for a variety of diseases. For example, PDK3 has been shown to be involved in the development of certain types of cancer, such as breast and ovarian cancer. It has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. In addition, PDK3 has been shown to be involved in the development of certain metabolic disorders, such as mitochondrial disease and diabetes.

The potential therapeutic uses of PDK3 are vast and varied. For example, drugs that target PDK3 have been shown to be effective in treating a variety of conditions, including cancer, neurodegenerative diseases, and metabolic disorders. Some studies have shown that inhibiting PDK3 activity can lead to a regression of certain diseases, such as cancer and neurodegenerative diseases. In addition, drugs that target PDK3 have also been shown to be effective in treating certain side effects associated with certain therapies, such as chemotherapy.

PDK3 has also been shown to be involved in a variety of cellular processes that are important for human health and development. For example, PDK3 has been shown to play a key role in the regulation of cellular apoptosis, which is the process by which cells die when they have reached a certain level of dysfunction. It has also been shown to play a key role in the regulation of cellular signaling, which is the process by which cells communicate with one another.

In conclusion, PDK3 is a promising drug target for a variety of therapeutic applications. The failure of PDK3 to function correctly can lead to a range of physiological and therapeutic issues, including cancer, neurodegenerative diseases, and metabolic disorders. The potential therapeutic uses of PDK3 are vast and varied, and the development of drugs that target PDK3 is an exciting area of research. Further research is needed to fully understand the role of PDK3 in various biological processes and to develop effective treatments for PDK3-related diseases.

Protein Name: Pyruvate Dehydrogenase Kinase 3

Functions: Inhibits pyruvate dehydrogenase activity by phosphorylation of the E1 subunit PDHA1, and thereby regulates glucose metabolism and aerobic respiration. Can also phosphorylate PDHA2. Decreases glucose utilization and increases fat metabolism in response to prolonged fasting, and as adaptation to a high-fat diet. Plays a role in glucose homeostasis and in maintaining normal blood glucose levels in function of nutrient levels and under starvation. Plays a role in the generation of reactive oxygen species

The "PDK3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDK3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets